AARP worried Congress will roll back Medicare drug changes

By Robert King

Published August 9, 2018 4:28pm ET

Add Washington Examiner on Google

AARP worried Congress will roll back Medicare drug changes — The AARP is warning lawmakers not to roll back a change to Medicare that forces drug companies to pay more for seniors’ drug costs. The senior citizen lobbying group issued a warning Wednesday to lawmakers who are seeking to revisit a decision Congress made in March to force drugmakers to offer a stiffer discount for […]

The AARP is warning lawmakers not to roll back a change to Medicare that forces drug companies to pay more for seniors’ drug costs.

The senior citizen lobbying group issued a warning Wednesday to lawmakers who are seeking to revisit a decision Congress made in March to force drugmakers to offer a stiffer discount for some Medicare seniors. More than 200 Republican and Democratic representatives have indicated they’re open to undoing the reform.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

AARP Congress Medicare and Medicaid Pharmaceutical Industry